Prognostic factors analysis for patient with BCLC intermediate stage hepatocellular carcinoma following transarterial chemoembolization
碩士 === 弘光科技大學 === 健康事業管理研究所 === 103 === Background: Transarterial chemoembolization (TACE) is the standard care for hepatocellular carcinoma (HCC) in BCLC intermediate stage ,and good responses to TACE account for better patient outcomes. For acheiving good responses to TACE , patients may need to...
Main Authors: | Chieh- Ling Yen, 顏潔翎 |
---|---|
Other Authors: | Chiu-Yueh Yang |
Format: | Others |
Language: | zh-TW |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/awjr86 |
Similar Items
-
Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
by: Jun Young Kim, et al.
Published: (2016-06-01) -
Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
by: Liu KC, et al.
Published: (2020-08-01) -
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
by: Marco Biolato, et al.
Published: (2018-01-01) -
Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
by: Shiguang Chen, et al.
Published: (2018-11-01) -
A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma
by: Jie Mei, et al.
Published: (2020-01-01)